Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹-547 Cr₹-38 Cr₹389 Cr₹19 Cr₹255 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS is ₹-547 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹-547 Cr
Mar2025₹-38 Cr
Mar2024₹389 Cr
Mar2023₹19 Cr
Mar2022₹255 Cr

How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹-547 Cr
Negative
Mar2025 ₹-38 Cr
Negative
Mar2024 ₹389 Cr
1,902.17
Mar2023 ₹19 Cr
-92.37
Mar2022 ₹255 Cr -

Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹75,626.8 Cr 7.9% 17.4% 36.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

7.9%

17.4%

36.6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses